17Beta-estradiol modulates endothelin-1 expression and release in human endothelial cells

Area of Science:

• Cardiovascular Biology
• Endocrinology
• Molecular Biology

Background:

• Endothelin-1 (ET-1) is a potent vasoconstrictor implicated in cardiovascular diseases.
• 17beta-estradiol (E2) is a key female hormone with known cardiovascular protective effects.
• The precise mechanisms underlying E2's cardiovascular benefits are still under investigation.

Purpose of the Study:

• To investigate the role of 17beta-estradiol (E2) in regulating endothelin-1 (ET-1) mRNA expression and secretion.
• To explore the involvement of nitric oxide (NO) in E2-mediated effects on ET-1.
• To elucidate the cellular mechanisms of E2's impact on endothelial function.

Main Methods:

• Cultured human umbilical vein endothelial cells (HUVECs) were treated with varying concentrations of E2.
• ET-1 mRNA expression was assessed using Northern blot analysis.
• ET-1 release was measured by radioimmunoassay, and cyclic guanosine 5'-monophosphate (cGMP) levels were determined.
• Nitric oxide synthase (NOS) inhibition was employed to assess NO's role.

Main Results:

• E2 significantly inhibited ET-1 mRNA expression and secretion in a dose-dependent manner.
• E2 treatment increased intracellular cGMP levels.
• Inhibition of NOS partially reversed E2's effect on ET-1 gene expression, suggesting a complex interplay.
• E2 reduced both basal and thrombin-stimulated ET-1 release.

Conclusions:

• 17beta-estradiol directly and indirectly regulates ET-1 gene expression and production in human endothelial cells.
• E2-induced nitric oxide production may contribute to decreased ET-1 levels.
• These findings suggest a potential mechanism for E2's protective effects on the cardiovascular system.